Lundbeck Notches Win In Danish Cipralex Case

Law360, New York (April 16, 2010, 2:36 PM EDT) -- Danish drug maker H. Lundbeck A/S has scored a ruling in its favor in one case but was dealt a setback in another in disputes with companies seeking to market generic versions of its antidepressant Cipralex.

Lundbeck said in a Friday statement that it was notified of a “favorable ruling” in a preliminary injunction case against wholesaler Pharmachange in the City Court in Elsinore in Denmark, which held that generic versions of escitalopram have to be removed from the Danish market.

That ruling can be appealed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.